Skip to main content
Ansa Biotechnologies, Inc.Form D offering

Ansa Biotechnologies, Inc. filed a Form D with the SEC, reporting $54.4M sold, of a $71.9M offering.

What happened

Ansa Biotechnologies, Inc. is a corporation based in Emeryville, California, and filed a Form D for a cash raise with a total offering amount of $71,903,290. The filing reports $54,403,290 sold to 18 investors and lists Jason Gammack and Daniel Lin-Arlow as executive officers/directors, with Yanniv Dorone, Brad Crutchfield, and Nate Cornell as directors.

Source

Extracted by Autobound

From the Signal API record
Signal
Form D offering

What this signalsNew funding often brings new budget and vendor reviews.

Amount
$54.4M
Location
EMERYVILLE, CALIFORNIA
Filed
Nov 18, 2026
Jurisdiction
Delaware
Business location
Emeryville, CA

More form D offering signals at other companies

The full record

From the Signal API record

People

  • Jason GammackExecutive Officer, Director · Named in the filing
  • Daniel Lin-ArlowExecutive Officer, Director · Named in the filing
  • Yanniv DoroneDirector · Named in the filing
  • Brad CrutchfieldDirector · Named in the filing
  • Nate CornellDirector · Named in the filing
  • Nick NaclerioDirector · Named in the filing
  • Chenny ZhangDirector · Named in the filing
  • Matthias ArenskotterExecutive Officer · Named in the filing

Numbers

Amount (USD)
$54.4M
Investors
18
Remaining (USD)
$17.5M
Offering size (USD)
$71.9M

Details

CIK
0001816722
Form
D
Entity type
Corporation
Primary topic
Biotechnology
Revenue range
Decline to Disclose
Business state
CA
Accession number
0001231919-26-001596
Resolved entity type
Operating company
Has non accredited investors
No

Topics and mentions

Topics

  • Private Placement
  • Biotechnology
  • Corporation

Exemptions

  • 06b

Securities

  • Equity

Extraction

Confidence
High
Relevance
60%
Detected
Nov 18, 2026
signal_type
sec-form-d-funding
signal_subtype
newFilingCompany

Use this data

Get every form D offering signal for Ansa Biotechnologies, Inc. and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Ansa Biotechnologies, Inc. this week?”

  2. Send it to your own tools

    The Signal API returns form D offering signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-form-d-funding record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/fd-0001231919-26-001596 returns this record as JSON. POST /v1/companies/enrich returns every signal for ansabio.com.

{
  "signal_id": "fd-0001231919-26-001596",
  "signal_type": "sec-form-d-funding",
  "signal_subtype": "newFilingCompany",
  "detected_at": "2026-11-18T00:00:00+00:00",
  "company": {
    "name": "Ansa Biotechnologies, Inc.",
    "domain": "ansabio.com"
  },
  "data": {
    "cik": "0001816722",
    "phone": "9256908100",
    "detail": "The filing indicates a private securities offering by a biotechnology company, but it does not provide operating details beyond the disclosed entity type, location, and key personnel. With no website resolved, the company’s business activities should be treated as unconfirmed from this record alone.",
    "topics": [
      "Private Placement",
      "Biotechnology",
      "Corporation"
    ],
    "summary": "Ansa Biotechnologies, Inc. is a corporation based in Emeryville, California, and filed a Form D for a cash raise with a total offering amount of $71,903,290. The filing reports $54,403,290 sold to 18 investors and lists Jason Gammack and Daniel Lin-Arlow as executive officers/directors, with Yanniv Dorone, Brad Crutchfield, and Nate Cornell as directors.",
    "website": "https://ansabio.com",
    "location": "EMERYVILLE, CALIFORNIA",
    "file_date": "2026-11-18",
    "form_type": "D",
    "relevance": 0.6,
    "confidence": "high",
    "exemptions": [
      "06b"
    ],
    "filing_url": "https://www.sec.gov/Archives/edgar/data/1816722/000123191926001596/",
    "source_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001816722&type=D&dateb=&owner=include&count=40",
    "entity_name": "Ansa Biotechnologies, Inc.",
    "entity_type": "Corporation",
    "jurisdiction": "DELAWARE",
    "primary_topic": "Biotechnology",
    "revenue_range": "Decline to Disclose",
    "business_state": "CA",
    "industry_group": "Biotechnology",
    "related_persons": [
      {
        "name": "Jason Gammack",
        "email": "j***@ansabio.com",
        "roles": [
          "Executive Officer",
          "Director"
        ],
        "linkedin_url": "https://www.linkedin.com/in/jasontgammack"
      },
      {
        "name": "Daniel Lin-Arlow",
        "roles": [
          "Executive Officer",
          "Director"
        ]
      },
      {
        "name": "Yanniv Dorone",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Brad Crutchfield",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Nate Cornell",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Nick Naclerio",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Chenny Zhang",
        "roles": [
          "Director"
        ]
      },
      {
        "name": "Matthias Arenskotter",
        "roles": [
          "Executive Officer"
        ]
      }
    ],
    "total_investors": 18,
    "total_remaining": 17500000,
    "accession_number": "0001231919-26-001596",
    "securities_types": [
      "Equity"
    ],
    "business_location": "Emeryville, CA",
    "total_amount_sold": 54403290,
    "resolved_entity_name": "Ansa Biotechnologies",
    "resolved_entity_type": "operating_company",
    "total_offering_amount": 71903290,
    "company_domain_confidence": 10,
    "has_non_accredited_investors": false
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.